Chevy Chase Trust Holdings, Inc. Guardant Health, Inc. Transaction History

Chevy Chase Trust Holdings, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$28.82 - $77.35 $1.17 Million - $3.14 Million	-40,549 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$48.25 - $100.49 $26.3 Million - $54.7 Million	-544,048 Reduced 93.06%	40,549 $2.69 Million
Q4 2021 Jan 31, 2022	SELL	$88.71 - $120.43 $653,615 - $887,328	-7,368 Reduced 1.24%	584,597 $58.5 Million
Q3 2021 Oct 20, 2021	BUY	$98.77 - $132.17 $264,703 - $354,215	2,680 Added 0.45%	591,965 $74 Million
Q2 2021 Jul 20, 2021	BUY	$109.77 - $165.68 $2.32 Million - $3.5 Million	21,137 Added 3.72%	589,285 $73.2 Million
Q1 2021 Apr 22, 2021	BUY	$127.04 - $179.1 $811,277 - $1.14 Million	6,386 Added 1.14%	568,148 $86.7 Million
Q4 2020 Feb 12, 2021	BUY	$99.96 - $135.93 $3.17 Million - $4.31 Million	31,690 Added 5.98%	561,762 $72.4 Million
Q3 2020 Nov 06, 2020	BUY	$80.32 - $111.8 $8.33 Million - $11.6 Million	103,726 Added 24.33%	530,072 $59.3 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $3.83 Million - $6.17 Million	63,313 Added 17.44%	426,346 $34.6 Million
Q1 2020 May 13, 2020	BUY	$59.04 - $88.81 $21.4 Million - $32.2 Million	363,033 New	363,033 $25.3 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.